Skip to Content

1427 5 (Farxiga 5 mg)

Generic Name: dapagliflozin

Pill with imprint 1427 5 is Yellow, Round and has been identified as Farxiga 5 mg. It is supplied by Bristol-Myers Squibb Company.

Farxiga is used in the treatment of heart failure; diabetes, type 2; heart failure with reduced ejection fraction and belongs to the drug class SGLT-2 inhibitors. Risk cannot be ruled out during pregnancy. Farxiga 5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 1427 5

Farxiga

Generic Name
dapagliflozin
Imprint
1427 5
Strength
5 mg
Color
Yellow
Shape
Round
Availability
Prescription only
Drug Class
SGLT-2 inhibitors
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Bristol-Myers Squibb Company

Labelers / Repackagers

NDC CodeLabeler / Repackager
00003-1427
00310-6205 AstraZeneca

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.